Evidence map›Paper›PMID 40894168›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Overcoming Barriers to Warfarin Patient Self-Management (PSM) in the US Healthcare System: Implementation Trial Study Protocol.

Heeseung Hong, Aaron S Wilson, Aubrey E Jones, Sara R Vazquez, Spencer Gilbert, Daniel C Malone, Nathorn Chaiyakunapruk, Jordan B King, Geoffrey D Barnes, Katelyn W Sylvester and 6 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Heeseung HongUniversity of Utah College of Pharmacy, Salt Lake City, Utah.
Aaron S WilsonUniversity of Utah College of Pharmacy, Salt Lake City, Utah.
Aubrey E JonesUniversity of Utah College of Pharmacy, Salt Lake City, Utah.
Sara R VazquezUniversity of Utah College of Pharmacy, Salt Lake City, Utah.
Spencer GilbertUniversity of Utah College of Pharmacy, Salt Lake City, Utah.
Daniel C MaloneUniversity of Utah College of Pharmacy, Salt Lake City, Utah.
Nathorn ChaiyakunaprukUniversity of Utah College of Pharmacy, Salt Lake City, Utah.
Jordan B KingUniversity of Utah School of Medicine, Salt Lake City, Utah.
Geoffrey D BarnesUniversity of Michigan, Ann Arbor, Michigan.
Katelyn W SylvesterBrigham and Women's Hospital, Boston, Massachusetts.
Gina DubeBrigham and Women's Hospital, Boston, Massachusetts.
Nicole V IrvingBrigham and Women's Hospital, Boston, Massachusetts.
Linh ChanLoma Linda VA, Loma Linda, California.
Bishoy RaghebEastern Colorado VA, Aurora, Colorado.
Thomas DelateKaiser Permanente National Pharmacy, Aurora, Colorado.
Daniel M WittUniversity of Utah College of Pharmacy, Salt Lake City, Utah.ORCID 0000-0002-3930-8358

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
AHRQ HHS R18 HS027960NCATS NIH HHS UL1 TR002538
6 · The paper itself

Abstract

Introduction: Warfarin is a narrow therapeutic index drug that requires frequent monitoring using the international normalized ratio (INR). Current clinic-based INR monitoring models lead to suboptimal warfarin management. Warfarin patient self-management (PSM) has consistently demonstrated superior efficacy compared to clinic-based management but is virtually unused in the US healthcare system. The objective of this study is to implement PSM in the US healthcare system using strategies developed to overcome previously identified barriers associated with PSM underutilization as well as potential PSM facilitators. Methods and analysis: We aim to implement PSM with 150 adult patients at four sites using strategies developed to address barriers to PSM specific to the US healthcare system. Implementation strategies will be guided by the Consolidated Framework for Implementation Research and the Quality Implementation Framework supported by Rapid Cycle Research Methodology. A type III hybrid implementation-effectiveness study design will be used to assess PSM implementation strategy outcomes while also gathering information on PSM clinical outcomes centered on the five elements of the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance). This study will be approved by the ethics boards at all participating sites. Discussion: We plan to disseminate the results of this research program examining the feasibility of PSM in US anticoagulation management services in scientific journals and conferences, as well as making elements of the PSM implementation toolkit publicly and freely available.

Identifiers

PMID40894168
PMCPMC12393654

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.